Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Long-term central venous access. Experience with 173 cases].

A Valeri1, A Borrelli, M Bontà

  • 1Azienda Ospedaliera Careggi, Firenze.

Minerva Chirurgica
|January 19, 2000
PubMed
Summary

This study reports on 173 long-term central venous accesses, finding low complication rates for both implantable ports and external tunneled catheters. Recommendations are made for device selection based on therapy duration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026
Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026
Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026
Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026
Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026
Same author

Phase I Clinical Study of DOC1021 (dubodencel) for Adjuvant Immunotherapy of Glioblastoma.

medRxiv : the preprint server for health sciences·2026

Area of Science:

  • Vascular Surgery
  • Oncology
  • Medical Devices

Context:

  • Long-term central venous access is crucial for managing patients with neoplastic diseases requiring extended therapies.
  • Evaluating the safety and efficacy of different central venous access devices is essential for patient care.
  • This study reviews personal experience with various central venous access devices over an eight-year period.

Purpose:

  • To report the utility and complication rates of long-term central venous accesses.
  • To compare the outcomes of totally implantable devices versus external tunneled catheters.
  • To provide recommendations for device selection based on therapy duration and patient condition.

Summary:

  • A total of 173 long-term central venous accesses were performed in 172 patients, primarily those with cancer.

Related Experiment Videos

  • Complication rates were low overall (7.4%), with no significant difference between totally implantable devices (59%) and external tunneled catheters (41%).
  • Key factors for low complications included strict aseptic techniques, fluoroscopic guidance, and diligent postoperative care.

    • Impact:

    • The findings support the safe use of both implantable ports and tunneled catheters for long-term venous access.
    • Recommendations guide clinicians in selecting the optimal device for short-term (tunneled catheter) versus long-term (implantable device) therapies.
    • This evidence contributes to improved patient management and reduced complications in oncological and parenteral nutrition settings.